Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.

Farragher, Tracey M

Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. [electronic resource] - Arthritis care & research May 2010 - 664-75 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

2151-4658

10.1002/acr.20207 doi


Adolescent
Adult
Aged
Antirheumatic Agents--therapeutic use
Arthritis--blood
Arthritis, Rheumatoid--blood
Autoantibodies--blood
Cohort Studies
Disease Progression
Female
Humans
Longitudinal Studies
Male
Middle Aged
Peptides, Cyclic--immunology
Predictive Value of Tests
Registries
Rheumatoid Factor--blood
Severity of Illness Index
Treatment Outcome
Young Adult